LogicMark Inc
LGMK0.011USD
-0.001-5.74%
Handelsschluss 08/04, 16:00（ET）Kurse um 15 Minuten verzögert
1.92MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über LogicMark Inc Unternehmen
LogicMark, Inc. provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform. The Company’s devices provide people with the ability to receive care at home and age independently. Its PERS devices incorporate two-way voice communication technology directly in the medical alert pendant. These PERS technologies are sold direct-to-consumer through the Company’s e-commerce Website, through dealers and distributors, as well as through the United States Veterans Health Administration (VHA). It provides no monthly fee products, which only require a one-time purchase expense, instead of a contract with recurring monthly charges. Its no monthly fee products contact family, friends, or 911 directly, eliminating the recurring monthly fee from a monitoring center. Its PERS products include Guardian Alert 911 Plus, Freedom Alert Plus, Guardian Alert 911, Freedom Alert Mini, and more.
Unternehmensinformationen
BörsenkürzelLGMK
Name des UnternehmensLogicMark Inc
IPO-datumAug 02, 2013
CEOMs. Chialin Simmons, J.D.
Anzahl der mitarbeiter31
WertpapierartOrdinary Share
GeschäftsjahresendeAug 02
Addresse2801 Diode Lane
StadtLOUISVILLE
BörseUS 'Other OTC' and Grey Market
LandUnited States of America
Postleitzahl40299
Telefon15024427911
Websitehttps://www.logicmark.com/
BörsenkürzelLGMK
IPO-datumAug 02, 2013
CEOMs. Chialin Simmons, J.D.
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Mark Archer
Mr. Mark Archer
Chief Financial Officer
Chief Financial Officer
42.01K
--
Ms. Carine Schneider
Ms. Carine Schneider
Independent Director
Independent Director
880.00
--
Ms. Barbara Gutierrez
Ms. Barbara Gutierrez
Independent Director
Independent Director
860.00
--
Mr. John P. Pettitt
Mr. John P. Pettitt
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Robert A. Curtis, Pharm.D.
Dr. Robert A. Curtis, Pharm.D.
Independent Director
Independent Director
--
--
Ms. Chialin Simmons, J.D.
Ms. Chialin Simmons, J.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Mark Archer
Mr. Mark Archer
Chief Financial Officer
Chief Financial Officer
42.01K
--
Ms. Carine Schneider
Ms. Carine Schneider
Independent Director
Independent Director
880.00
--
Ms. Barbara Gutierrez
Ms. Barbara Gutierrez
Independent Director
Independent Director
860.00
--
Mr. John P. Pettitt
Mr. John P. Pettitt
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Robert A. Curtis, Pharm.D.
Dr. Robert A. Curtis, Pharm.D.
Independent Director
Independent Director
--
--
Ms. Chialin Simmons, J.D.
Ms. Chialin Simmons, J.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Umsatzaufteilung
Keine Daten
Keine Daten
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Fri, May 16
Aktualisiert: Fri, May 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Sabby Management, LLC
1.22%
Altium Capital Management LP
0.94%
L1 Capital Global Opportunities Master Fund Ltd.
0.85%
Hudson Bay Capital Management LP
0.26%
Renaissance Technologies LLC
0.11%
Other
96.63%
Aktionäre
Aktionäre
Anteil
Sabby Management, LLC
1.22%
Altium Capital Management LP
0.94%
L1 Capital Global Opportunities Master Fund Ltd.
0.85%
Hudson Bay Capital Management LP
0.26%
Renaissance Technologies LLC
0.11%
Other
96.63%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
2.16%
Corporation
0.85%
Hedge Fund
0.45%
Individual Investor
0.03%
Other
96.51%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
43
20.18M
3.57%
+19.04M
2025Q1
46
20.18M
3.50%
+19.04M
2024Q4
46
305.36K
10.34%
+114.75K
2024Q3
45
40.37K
8.11%
+7.47K
2024Q2
40
13.51K
15.38%
-18.17K
2024Q1
40
12.21K
20.39%
-17.08K
2023Q4
48
11.66K
19.75%
-18.11K
2023Q3
50
11.30K
93.79%
-14.22K
2023Q2
50
24.28K
166.02%
+15.47K
2023Q1
53
8.89K
204.40%
+594.00
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Sabby Management, LLC
7.04M
1.22%
+6.96M
+8467.91%
Mar 31, 2025
Altium Capital Management LP
5.40M
0.94%
+5.38M
+37367.42%
Mar 31, 2025
L1 Capital Global Opportunities Master Fund Ltd.
4.88M
0.85%
+4.38M
+876.25%
Mar 31, 2025
Hudson Bay Capital Management LP
1.50M
0.26%
+1.45M
+3091.49%
Mar 31, 2025
Renaissance Technologies LLC
612.11K
0.11%
+612.11K
--
Mar 31, 2025
Bigger Capital Funds, LP
490.00K
0.09%
+490.00K
--
Feb 18, 2025
Simmons (Chia-Lin J.D.)
123.03K
0.02%
--
--
Mar 27, 2025
Archer (Mark)
42.01K
0.01%
--
--
Mar 27, 2025
Jane Street Capital, L.L.C.
40.93K
0.01%
+40.93K
--
Mar 31, 2025
Geode Capital Management, L.L.C.
21.72K
0%
+19.54K
+897.06%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Name
Anteil
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Nov 15, 2024
Merger
25<1
Nov 15, 2024
Merger
25<1
Nov 15, 2024
Merger
25<1
Nov 15, 2024
Merger
25<1
Apr 21, 2023
Merger
20<1
Apr 21, 2023
Merger
20<1
Datum
Art
Verhältnis
Nov 15, 2024
Merger
25<1
Nov 15, 2024
Merger
25<1
Nov 15, 2024
Merger
25<1
Nov 15, 2024
Merger
25<1
Apr 21, 2023
Merger
20<1
Apr 21, 2023
Merger
20<1
Apr 21, 2023
Merger
20<1
Apr 21, 2023
Merger
20<1
Oct 15, 2021
Merger
10<1
Oct 15, 2021
Merger
10<1
Mehr Anzeigen
